Johnson & Johnson
NYSE: JNJ
$145.85
+$0.58 (+0.4%)
Closing Price on December 24, 2024
JNJ Articles
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Published:
Last Updated:
Johnson & Johnson still cannot escape the shadow of its Johnson's Baby Powder brand talc and asbestos lawsuits and overhang.
Published:
Last Updated:
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
Published:
Last Updated:
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
Published:
Last Updated:
24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price. We have also added in some additional color on these companies as well.
Published:
Last Updated:
Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Now that the fourth-quarter earnings reporting season has kicked off, more major companies will be sharing their results this week, including Comcast, Ford and Intel.
Published:
Last Updated:
These two members of the thirty Dow Jones industrial average index have been under siege and are now fighting back.
Published:
Last Updated:
Johnson & Johnson shares dropped on Friday after it came public that the company knew for decades that its baby powder sometimes contained the known carcinogen asbestos.
Published:
Last Updated:
Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019 rather than looking back at how choppy 2018 has been.
Published:
Last Updated:
These 10 companies that are likely to have safer business models and will offer some defensive positioning if the economic strength of 2018 is not repeated in 2019.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected third-quarter financial results before the markets opened on Thursday.
Published:
Last Updated:
Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.
Published:
Last Updated:
Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Published:
Last Updated: